 |
 Preclinical DevelopmentThe hemostatic effects of Fibrocaps™ have been investigated in a number of animal models. The preclinical studies have among others included liver biopsies and liver resection in pigs (see images below). The pig model has been widely used for evaluating new hemostatic treatments and is considered highly predictive for outcomes in human clinical trials Pig liver biopsy (left image) and liver resection (right image) sealed with Fibrocaps dry powder fibrin sealant.The efficacy of Fibrocaps was assessed by determining the time required to obtain hemostasis in surgical wound bleedings. Fibrocaps proved to be a very potent hemostat and required significantly less fibrinogen than what is required in liquid fibrin sealants or other fibrinogen/thrombin formulated products. |
 |
 |
